IL10 and metabolic dysfunction-associated steatotic liver disease: In NAFLD and ACa groups, VSL#3 improved plasma levels of lipid peroxidation markers: MDA, 4-HNE. In AC patients, cytokines (TNF-α, IL-6 and IL-10) improved. S-NO plasma levels improved in all groups